文献速递淋巴瘤

慢性淋巴细胞白血病与套细胞淋巴瘤:遗传与微环境相互作用的交叉点

Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.
PubMed 文献 · Blood · 2018-04-17

本文综述慢性淋巴细胞白血病(CLL)与套细胞淋巴瘤(MCL)在流行病学特征、起源细胞、分子改变和临床特征上的异同,重点阐述B细胞受体信号、肿瘤微环境相互作用、基因组改变和表观基因组修饰对两者演化及治疗干预的影响。

要点

  • CLL与MCL均包含两个主要分子亚型,分别来源于保留初始或记忆样表观遗传特征的CD5+ B细胞。
  • 两肿瘤的致病机制整合B细胞受体信号、微环境相互作用、基因组改变和表观基因组修饰。
  • 初始样来源肿瘤较记忆样来源肿瘤在CLL和MCL中均更具侵袭性。

核心结论

  • CLL和MCL的发病机制整合了B细胞受体信号、肿瘤细胞微环境相互作用、基因组改变和表观基因组修饰的影响,这些因素塑造肿瘤演化并为治疗干预提供新可能。

研究设计与样本

  • 本文为综述,基于近期研究聚焦CLL与MCL的相似性与差异。

主要发现

  • CLL和MCL经典上分别被认为是惰性和侵袭性肿瘤,但两者临床演化均高度异质,部分患者长期稳定而另一些需立即干预。
  • CLL和MCL均包含两个主要分子亚型,似乎来源于保留初始或记忆样表观遗传特征的抗原经验CD5+ B细胞,分别携带从真正未突变到高度突变的可变免疫球蛋白重链可变区体细胞突变负荷。
  • 两个亚型在分子通路、基因组改变和临床行为上不同,初始样来源肿瘤较记忆样来源肿瘤在CLL和MCL中均更具侵袭性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are 2 well-defined entities that diverge in their basic pathogenic mechanisms and clinical evolution but they share epidemiological characteristics, cells of origin, molecular alterations, and clinical features that differ from other lymphoid neoplasms. CLL and MCL are classically considered indolent and aggressive neoplasms, respectively. However, the clinical evolution of both tumors is very heterogeneous, with subsets of patients having stable disease for a long time whereas others require immediate intervention. Both CLL and MCL include 2 major molecular subtypes that seem to derive from antigen-experienced CD5+ B cells that retain a naive or memory-like epigenetic signature and carry a variable load of immunoglobulin heavy-chain variable region somatic mutations from truly unmutated to highly mutated, respectively. These 2 subtypes of tumors differ in their molecular pathways, genomic alterations, and clinical behavior, being more aggressive in naive-like than memory-like-derived tumors in both CLL and MCL. The pathogenesis of the 2 entities integrates the relevant influence of B-cell receptor signaling, tumor cell microenvironment interactions, genomic alterations, and epigenome modifications that configure the evolution of the tumors and offer new possibilities for therapeutic intervention. This review will focus on the similarities and differences of these 2 tumors based on recent studies that are enhancing the understanding of their pathogenesis and creating solid bases for new management strategies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Puente XS, Jares P, Campo E, et al. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood. 2018. PMID: 29666114. doi:10.1182/blood-2017-10-764373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。